These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 8929745

  • 1. Pharmacokinetics of thiamine derivatives especially of benfotiamine.
    Loew D.
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):47-50. PubMed ID: 8929745
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride.
    Xie F, Cheng Z, Li S, Liu X, Guo X, Yu P, Gu Z.
    J Clin Pharmacol; 2014 Jun; 54(6):688-95. PubMed ID: 24399744
    [Abstract] [Full Text] [Related]

  • 3. Comparative autoradiographic investigations on the tissue distribution of benfotiamine versus thiamine in mice.
    Hilbig R, Rahmann H.
    Arzneimittelforschung; 1998 May; 48(5):461-8. PubMed ID: 9638312
    [Abstract] [Full Text] [Related]

  • 4. Comparative bioavailability of various thiamine derivatives after oral administration.
    Greb A, Bitsch R.
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):216-21. PubMed ID: 9587048
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin Preparations.
    Park WS, Lee J, Hong T, Park G, Youn S, Seo Y, Lee S, Han S.
    Clin Ther; 2016 Oct; 38(10):2277-2285. PubMed ID: 27707509
    [Abstract] [Full Text] [Related]

  • 7. Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative.
    Bitsch R, Wolf M, Möller J, Heuzeroth L, Grüneklee D.
    Ann Nutr Metab; 1991 Oct; 35(5):292-6. PubMed ID: 1776825
    [Abstract] [Full Text] [Related]

  • 8. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine.
    Frank T, Bitsch R, Maiwald J, Stein G.
    Eur J Clin Pharmacol; 2000 Jun; 56(3):251-7. PubMed ID: 10952481
    [Abstract] [Full Text] [Related]

  • 9. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.
    Volvert ML, Seyen S, Piette M, Evrard B, Gangolf M, Plumier JC, Bettendorff L.
    BMC Pharmacol; 2008 Jun 12; 8():10. PubMed ID: 18549472
    [Abstract] [Full Text] [Related]

  • 10. Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate.
    Schreeb KH, Freudenthaler S, Vormfelde SV, Gundert-Remy U, Gleiter CH.
    Eur J Clin Pharmacol; 1997 Jun 12; 52(4):319-20. PubMed ID: 9248773
    [No Abstract] [Full Text] [Related]

  • 11. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
    Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D.
    Diabetes Care; 2006 Sep 12; 29(9):2064-71. PubMed ID: 16936154
    [Abstract] [Full Text] [Related]

  • 12. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose.
    Beltramo E, Berrone E, Buttiglieri S, Porta M.
    Diabetes Metab Res Rev; 2004 Sep 12; 20(4):330-6. PubMed ID: 15250036
    [Abstract] [Full Text] [Related]

  • 13. Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects.
    Sheng L, Cao W, Lin P, Chen W, Xu H, Zhong C, Yuan F, Chen H, Li H, Liu C, Yang M, Li X.
    Drug Des Devel Ther; 2021 Sep 12; 15():1101-1110. PubMed ID: 33727798
    [Abstract] [Full Text] [Related]

  • 14. Benfotiamine relieves inflammatory and neuropathic pain in rats.
    Sánchez-Ramírez GM, Caram-Salas NL, Rocha-González HI, Vidal-Cantú GC, Medina-Santillán R, Reyes-García G, Granados-Soto V.
    Eur J Pharmacol; 2006 Jan 13; 530(1-2):48-53. PubMed ID: 16359659
    [Abstract] [Full Text] [Related]

  • 15. Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro.
    Schmid U, Stopper H, Heidland A, Schupp N.
    Diabetes Metab Res Rev; 2008 Jan 13; 24(5):371-7. PubMed ID: 18384109
    [Abstract] [Full Text] [Related]

  • 16. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha.
    Wu S, Ren J.
    Neurosci Lett; 2006 Feb 13; 394(2):158-62. PubMed ID: 16260089
    [Abstract] [Full Text] [Related]

  • 17. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
    Karachalias N, Babaei-Jadidi R, Kupich C, Ahmed N, Thornalley PJ.
    Ann N Y Acad Sci; 2005 Jun 13; 1043():777-83. PubMed ID: 16037305
    [Abstract] [Full Text] [Related]

  • 18. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
    Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG.
    Exp Clin Endocrinol Diabetes; 2008 Nov 13; 116(10):600-5. PubMed ID: 18473286
    [Abstract] [Full Text] [Related]

  • 19. Anti-fatigue effect of dicethiamine hydrochloride is likely associated with excellent absorbability and high transformability in tissues as a Vitamin B(1).
    Shimizu T, Hoshino H, Nishi S, Nozaki S, Watanabe Y.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):117-23. PubMed ID: 20307527
    [Abstract] [Full Text] [Related]

  • 20. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.
    Beltramo E, Berrone E, Tarallo S, Porta M.
    Acta Diabetol; 2008 Sep 10; 45(3):131-41. PubMed ID: 18581039
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.